1. Home
  2. COEP vs CRIS Comparison

COEP vs CRIS Comparison

Compare COEP & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CRIS
  • Stock Information
  • Founded
  • COEP 2017
  • CRIS 2000
  • Country
  • COEP United States
  • CRIS United States
  • Employees
  • COEP N/A
  • CRIS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • COEP Health Care
  • CRIS Health Care
  • Exchange
  • COEP Nasdaq
  • CRIS Nasdaq
  • Market Cap
  • COEP 32.4M
  • CRIS 32.8M
  • IPO Year
  • COEP N/A
  • CRIS 2000
  • Fundamental
  • Price
  • COEP $12.31
  • CRIS $3.17
  • Analyst Decision
  • COEP
  • CRIS Strong Buy
  • Analyst Count
  • COEP 0
  • CRIS 3
  • Target Price
  • COEP N/A
  • CRIS $23.00
  • AVG Volume (30 Days)
  • COEP 121.3K
  • CRIS 34.1K
  • Earning Date
  • COEP 03-25-2025
  • CRIS 02-18-2025
  • Dividend Yield
  • COEP N/A
  • CRIS N/A
  • EPS Growth
  • COEP N/A
  • CRIS N/A
  • EPS
  • COEP N/A
  • CRIS N/A
  • Revenue
  • COEP N/A
  • CRIS $10,259,000.00
  • Revenue This Year
  • COEP N/A
  • CRIS N/A
  • Revenue Next Year
  • COEP N/A
  • CRIS N/A
  • P/E Ratio
  • COEP N/A
  • CRIS N/A
  • Revenue Growth
  • COEP N/A
  • CRIS 0.44
  • 52 Week Low
  • COEP $2.31
  • CRIS $2.86
  • 52 Week High
  • COEP $13.70
  • CRIS $17.49
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.60
  • CRIS 42.84
  • Support Level
  • COEP $8.65
  • CRIS $3.05
  • Resistance Level
  • COEP $13.70
  • CRIS $3.55
  • Average True Range (ATR)
  • COEP 1.89
  • CRIS 0.22
  • MACD
  • COEP -0.21
  • CRIS -0.00
  • Stochastic Oscillator
  • COEP 72.48
  • CRIS 20.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: